News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
213 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Lilly Appoints Philip Johnson to Senior VP and Treasurer
Eli Lilly today announced Philip Johnson has been appointed to senior VP, Finance, and treasurer effective January 1, 2018.
November 13, 2017
·
1 min read
Business
Jounce Therapeutics Reports Third Quarter 2017 Financial Results
Jounce has narrowed its financial guidance previously provided for the full year 2017.
November 13, 2017
·
11 min read
Pharm Country
Amarin Corporation: Real-World Data Analysis Shows That High Triglyceride Levels Are Associated With Increased Cardiovascular Events and Medical Costs
The analysis was presented at the 2017 American Heart Association (AHA) Scientific Sessions in Anaheim, CA.
November 13, 2017
·
9 min read
Business
CARMAT Signs a Partnership Agreement With AddUp, the Michelin and Fives Joint Venture Specialized in 3D Printing
CARMAT today announces that it has signed a partnership agreement with AddUp, the Joint Venture specialized in 3D printing set up by the Michelin and Fives groups.
November 13, 2017
·
5 min read
Business
Fennec Provides Business Update And Reports Third Quarter 2017 Results
Cash and cash equivalents were $9,688 at September 30, 2017 and $3,926 at December 31, 2016.
November 13, 2017
·
10 min read
Drug Development
NANOBIOTIX Presented New Clinical and Pre-Clinical Data Confirming NBTXR3’s Significant Potential Role in Immuno-Oncology at SITC Annual Meeting
Nanobiotix’s lead product, NBTXR3, has a universal physical mode of action which is designed for the local destruction of tumors.
November 13, 2017
·
8 min read
Evonik Industries: Launches New Sterile and Ultra-Low-Metal Content Bioresorbable Polymers
Evonik , a global leader in biomaterials, is expanding its RESOMER portfolio of bioresorbable polymers for controlled-release parenteral drug formulations.
November 13, 2017
·
3 min read
Business
Rexgenero Announces the Appointment of Sam MacHour to its Scientific Advisory Board
Rexgenero is pleased to announce today the appointment of Sam MacHour to its SAB.
November 13, 2017
·
2 min read
FDA
Nexstim Gains FDA Clearance to Commercialize Its NBT System to Treat Depression
The NBT system uses a unique method of TMS known as navigated Transcranial Magnetic Stimulation.
November 13, 2017
·
2 min read
Business
RedHill Biopharma Reports 2017 Third Quarter Financial Results
RedHill maintains a debt-free balance sheet with $39.6 million in cash1 at the end of the third quarter of 2017.
November 13, 2017
·
31 min read
Previous
12 of 22
Next